miR-216a promotes breast cancer cell apoptosis by targeting PKCα.
Cui Y, Wang J, Liu S, Qu D, Jin H, Zhu L, Yang J, Zhang J, Li Q, Zhang Y, Yao Y.
Cui Y, et al. Among authors: zhu l.
Fundam Clin Pharmacol. 2019 Aug;33(4):397-404. doi: 10.1111/fcp.12481. Epub 2019 May 31.
Fundam Clin Pharmacol. 2019.
PMID: 31119784